Brief: Pieris To Cut Workforce In Second Quarter

Palvella Therapeutics

27/03/2024 12:23

March 27 (Reuters) - Pieris Pharmaceuticals Inc
 PIRS.O :
    * PIERIS PHARMACEUTICALS ANNOUNCES STRATEGY TO MAXIMIZE
PARTNERED
MILESTONE AND ROYALTY POTENTIAL
    * PIERIS: ANNOUNCES WORKFORCE REDUCTION, EXPECTED TO BE
IMPLEMENTED IN Q2
    * PIERIS SEES DISCONTINUATION OF RESEARCH AND DEVELOPMENT
EFFORTS,
EXPECTED TO BE COMPLETED BY MIDDLE OF 2024
    * PIERIS PHARMACEUTICALS: PLAN TO REDUCE SIZE OF BOARD
    * PIERIS: DOES NOT EXPECT TO HAVE FUTURE FINANCING
REQUIREMENTS TO
ACHIEVE NEAR-TERM MILESTONE POTENTIAL OF PARTNERED PROGRAMS
    * PIERIS: MAY CONSIDER CASH DIVIDENDS AS AND WHEN MILESTONE
OR
OTHER PAYMENTS ARE RECEIVED
    * PIERIS -  TO PURSUING POSSIBLE MONETIZATION OF PROJECTED
ROYALTY, MILESTONE PAYMENTS CO MAY CONSIDER OTHER OPTIONS THAT
MAY INCREASE STOCKHOLDER VALUE

Source text for Eikon:  ID:n0001437749-24-009491 
Further company coverage:  PIRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))